3D Bioprinting-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data
Report Summary
3D Bioprinting-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on 3D Bioprinting industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of 3D Bioprinting 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of 3D Bioprinting worldwide and market share by regions, with company and product introduction, position in the 3D Bioprinting market
Market status and development trend of 3D Bioprinting by types and applications
Cost and profit status of 3D Bioprinting, and marketing status
Market growth drivers and challenges
The report segments the global 3D Bioprinting market as:
Global 3D Bioprinting Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global 3D Bioprinting Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Magnetic 3D Bioprinting
Laser-assisted Bioprinting
Inkjet 3D Bioprinting
Microextrusion 3D Bioprinting
Global 3D Bioprinting Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Clinical Applications
Research Applications
Drug and Medical Research
Regenerative Medicine
3D Cell Culture
Global 3D Bioprinting Market: Manufacturers Segment Analysis (Company and Product introduction, 3D Bioprinting Sales Volume, Revenue, Price and Gross Margin):
Organovo Holdings Inc.
EnvisionTEC GmbH
Nano3D Biosciences, Inc.
Cyfuse Biomedical K.K.
BioBots
Aspect Biosystems Ltd.
3Dynamic Systems Ltd.
regenHU Ltd
Cellink
Regenovo Biotechnology Co., Ltd.
Poietis
GeSiM
Exone
Stratasys
Bespoke Innovations
Advanced BioMatrix
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
3D Bioprinting-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on 3D Bioprinting industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of 3D Bioprinting 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of 3D Bioprinting worldwide and market share by regions, with company and product introduction, position in the 3D Bioprinting market
Market status and development trend of 3D Bioprinting by types and applications
Cost and profit status of 3D Bioprinting, and marketing status
Market growth drivers and challenges
The report segments the global 3D Bioprinting market as:
Global 3D Bioprinting Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global 3D Bioprinting Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Magnetic 3D Bioprinting
Laser-assisted Bioprinting
Inkjet 3D Bioprinting
Microextrusion 3D Bioprinting
Global 3D Bioprinting Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Clinical Applications
Research Applications
Drug and Medical Research
Regenerative Medicine
3D Cell Culture
Global 3D Bioprinting Market: Manufacturers Segment Analysis (Company and Product introduction, 3D Bioprinting Sales Volume, Revenue, Price and Gross Margin):
Organovo Holdings Inc.
EnvisionTEC GmbH
Nano3D Biosciences, Inc.
Cyfuse Biomedical K.K.
BioBots
Aspect Biosystems Ltd.
3Dynamic Systems Ltd.
regenHU Ltd
Cellink
Regenovo Biotechnology Co., Ltd.
Poietis
GeSiM
Exone
Stratasys
Bespoke Innovations
Advanced BioMatrix
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF 3D BIOPRINTING
1.1 Definition of 3D Bioprinting in This Report
1.2 Commercial Types of 3D Bioprinting
1.2.1 Magnetic 3D Bioprinting
1.2.2 Laser-assisted Bioprinting
1.2.3 Inkjet 3D Bioprinting
1.2.4 Microextrusion 3D Bioprinting
1.3 Downstream Application of 3D Bioprinting
1.3.1 Clinical Applications
1.3.2 Research Applications
1.3.3 Drug and Medical Research
1.3.4 Regenerative Medicine
1.3.5 3D Cell Culture
1.4 Development History of 3D Bioprinting
1.5 Market Status and Trend of 3D Bioprinting 2013-2023
1.5.1 Global 3D Bioprinting Market Status and Trend 2013-2023
1.5.2 Regional 3D Bioprinting Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of 3D Bioprinting 2013-2017
2.2 Sales Market of 3D Bioprinting by Regions
2.2.1 Sales Volume of 3D Bioprinting by Regions
2.2.2 Sales Value of 3D Bioprinting by Regions
2.3 Production Market of 3D Bioprinting by Regions
2.4 Global Market Forecast of 3D Bioprinting 2018-2023
2.4.1 Global Market Forecast of 3D Bioprinting 2018-2023
2.4.2 Market Forecast of 3D Bioprinting by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of 3D Bioprinting by Types
3.2 Sales Value of 3D Bioprinting by Types
3.3 Market Forecast of 3D Bioprinting by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of 3D Bioprinting by Downstream Industry
4.2 Global Market Forecast of 3D Bioprinting by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America 3D Bioprinting Market Status by Countries
5.1.1 North America 3D Bioprinting Sales by Countries (2013-2017)
5.1.2 North America 3D Bioprinting Revenue by Countries (2013-2017)
5.1.3 United States 3D Bioprinting Market Status (2013-2017)
5.1.4 Canada 3D Bioprinting Market Status (2013-2017)
5.1.5 Mexico 3D Bioprinting Market Status (2013-2017)
5.2 North America 3D Bioprinting Market Status by Manufacturers
5.3 North America 3D Bioprinting Market Status by Type (2013-2017)
5.3.1 North America 3D Bioprinting Sales by Type (2013-2017)
5.3.2 North America 3D Bioprinting Revenue by Type (2013-2017)
5.4 North America 3D Bioprinting Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe 3D Bioprinting Market Status by Countries
6.1.1 Europe 3D Bioprinting Sales by Countries (2013-2017)
6.1.2 Europe 3D Bioprinting Revenue by Countries (2013-2017)
6.1.3 Germany 3D Bioprinting Market Status (2013-2017)
6.1.4 UK 3D Bioprinting Market Status (2013-2017)
6.1.5 France 3D Bioprinting Market Status (2013-2017)
6.1.6 Italy 3D Bioprinting Market Status (2013-2017)
6.1.7 Russia 3D Bioprinting Market Status (2013-2017)
6.1.8 Spain 3D Bioprinting Market Status (2013-2017)
6.1.9 Benelux 3D Bioprinting Market Status (2013-2017)
6.2 Europe 3D Bioprinting Market Status by Manufacturers
6.3 Europe 3D Bioprinting Market Status by Type (2013-2017)
6.3.1 Europe 3D Bioprinting Sales by Type (2013-2017)
6.3.2 Europe 3D Bioprinting Revenue by Type (2013-2017)
6.4 Europe 3D Bioprinting Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific 3D Bioprinting Market Status by Countries
7.1.1 Asia Pacific 3D Bioprinting Sales by Countries (2013-2017)
7.1.2 Asia Pacific 3D Bioprinting Revenue by Countries (2013-2017)
7.1.3 China 3D Bioprinting Market Status (2013-2017)
7.1.4 Japan 3D Bioprinting Market Status (2013-2017)
7.1.5 India 3D Bioprinting Market Status (2013-2017)
7.1.6 Southeast Asia 3D Bioprinting Market Status (2013-2017)
7.1.7 Australia 3D Bioprinting Market Status (2013-2017)
7.2 Asia Pacific 3D Bioprinting Market Status by Manufacturers
7.3 Asia Pacific 3D Bioprinting Market Status by Type (2013-2017)
7.3.1 Asia Pacific 3D Bioprinting Sales by Type (2013-2017)
7.3.2 Asia Pacific 3D Bioprinting Revenue by Type (2013-2017)
7.4 Asia Pacific 3D Bioprinting Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America 3D Bioprinting Market Status by Countries
8.1.1 Latin America 3D Bioprinting Sales by Countries (2013-2017)
8.1.2 Latin America 3D Bioprinting Revenue by Countries (2013-2017)
8.1.3 Brazil 3D Bioprinting Market Status (2013-2017)
8.1.4 Argentina 3D Bioprinting Market Status (2013-2017)
8.1.5 Colombia 3D Bioprinting Market Status (2013-2017)
8.2 Latin America 3D Bioprinting Market Status by Manufacturers
8.3 Latin America 3D Bioprinting Market Status by Type (2013-2017)
8.3.1 Latin America 3D Bioprinting Sales by Type (2013-2017)
8.3.2 Latin America 3D Bioprinting Revenue by Type (2013-2017)
8.4 Latin America 3D Bioprinting Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa 3D Bioprinting Market Status by Countries
9.1.1 Middle East and Africa 3D Bioprinting Sales by Countries (2013-2017)
9.1.2 Middle East and Africa 3D Bioprinting Revenue by Countries (2013-2017)
9.1.3 Middle East 3D Bioprinting Market Status (2013-2017)
9.1.4 Africa 3D Bioprinting Market Status (2013-2017)
9.2 Middle East and Africa 3D Bioprinting Market Status by Manufacturers
9.3 Middle East and Africa 3D Bioprinting Market Status by Type (2013-2017)
9.3.1 Middle East and Africa 3D Bioprinting Sales by Type (2013-2017)
9.3.2 Middle East and Africa 3D Bioprinting Revenue by Type (2013-2017)
9.4 Middle East and Africa 3D Bioprinting Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF 3D BIOPRINTING
10.1 Global Economy Situation and Trend Overview
10.2 3D Bioprinting Downstream Industry Situation and Trend Overview
CHAPTER 11 3D BIOPRINTING MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of 3D Bioprinting by Major Manufacturers
11.2 Production Value of 3D Bioprinting by Major Manufacturers
11.3 Basic Information of 3D Bioprinting by Major Manufacturers
11.3.1 Headquarters Location and Established Time of 3D Bioprinting Major Manufacturer
11.3.2 Employees and Revenue Level of 3D Bioprinting Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 3D BIOPRINTING MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Organovo Holdings Inc.
12.1.1 Company profile
12.1.2 Representative 3D Bioprinting Product
12.1.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of Organovo Holdings Inc.
12.2 EnvisionTEC GmbH
12.2.1 Company profile
12.2.2 Representative 3D Bioprinting Product
12.2.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of EnvisionTEC GmbH
12.3 Nano3D Biosciences, Inc.
12.3.1 Company profile
12.3.2 Representative 3D Bioprinting Product
12.3.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of Nano3D Biosciences, Inc.
12.4 Cyfuse Biomedical K.K.
12.4.1 Company profile
12.4.2 Representative 3D Bioprinting Product
12.4.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of Cyfuse Biomedical K.K.
12.5 BioBots
12.5.1 Company profile
12.5.2 Representative 3D Bioprinting Product
12.5.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of BioBots
12.6 Aspect Biosystems Ltd.
12.6.1 Company profile
12.6.2 Representative 3D Bioprinting Product
12.6.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of Aspect Biosystems Ltd.
12.7 3Dynamic Systems Ltd.
12.7.1 Company profile
12.7.2 Representative 3D Bioprinting Product
12.7.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of 3Dynamic Systems Ltd.
12.8 regenHU Ltd
12.8.1 Company profile
12.8.2 Representative 3D Bioprinting Product
12.8.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of regenHU Ltd
12.9 Cellink
12.9.1 Company profile
12.9.2 Representative 3D Bioprinting Product
12.9.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of Cellink
12.10 Regenovo Biotechnology Co., Ltd.
12.10.1 Company profile
12.10.2 Representative 3D Bioprinting Product
12.10.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of Regenovo Biotechnology Co., Ltd.
12.11 Poietis
12.11.1 Company profile
12.11.2 Representative 3D Bioprinting Product
12.11.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of Poietis
12.12 GeSiM
12.12.1 Company profile
12.12.2 Representative 3D Bioprinting Product
12.12.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of GeSiM
12.13 Exone
12.13.1 Company profile
12.13.2 Representative 3D Bioprinting Product
12.13.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of Exone
12.14 Stratasys
12.14.1 Company profile
12.14.2 Representative 3D Bioprinting Product
12.14.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of Stratasys
12.15 Bespoke Innovations
12.15.1 Company profile
12.15.2 Representative 3D Bioprinting Product
12.15.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of Bespoke Innovations
12.16 Advanced BioMatrix
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF 3D BIOPRINTING
13.1 Industry Chain of 3D Bioprinting
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF 3D BIOPRINTING
14.1 Cost Structure Analysis of 3D Bioprinting
14.2 Raw Materials Cost Analysis of 3D Bioprinting
14.3 Labor Cost Analysis of 3D Bioprinting
14.4 Manufacturing Expenses Analysis of 3D Bioprinting
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of 3D Bioprinting in This Report
1.2 Commercial Types of 3D Bioprinting
1.2.1 Magnetic 3D Bioprinting
1.2.2 Laser-assisted Bioprinting
1.2.3 Inkjet 3D Bioprinting
1.2.4 Microextrusion 3D Bioprinting
1.3 Downstream Application of 3D Bioprinting
1.3.1 Clinical Applications
1.3.2 Research Applications
1.3.3 Drug and Medical Research
1.3.4 Regenerative Medicine
1.3.5 3D Cell Culture
1.4 Development History of 3D Bioprinting
1.5 Market Status and Trend of 3D Bioprinting 2013-2023
1.5.1 Global 3D Bioprinting Market Status and Trend 2013-2023
1.5.2 Regional 3D Bioprinting Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of 3D Bioprinting 2013-2017
2.2 Sales Market of 3D Bioprinting by Regions
2.2.1 Sales Volume of 3D Bioprinting by Regions
2.2.2 Sales Value of 3D Bioprinting by Regions
2.3 Production Market of 3D Bioprinting by Regions
2.4 Global Market Forecast of 3D Bioprinting 2018-2023
2.4.1 Global Market Forecast of 3D Bioprinting 2018-2023
2.4.2 Market Forecast of 3D Bioprinting by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of 3D Bioprinting by Types
3.2 Sales Value of 3D Bioprinting by Types
3.3 Market Forecast of 3D Bioprinting by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of 3D Bioprinting by Downstream Industry
4.2 Global Market Forecast of 3D Bioprinting by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America 3D Bioprinting Market Status by Countries
5.1.1 North America 3D Bioprinting Sales by Countries (2013-2017)
5.1.2 North America 3D Bioprinting Revenue by Countries (2013-2017)
5.1.3 United States 3D Bioprinting Market Status (2013-2017)
5.1.4 Canada 3D Bioprinting Market Status (2013-2017)
5.1.5 Mexico 3D Bioprinting Market Status (2013-2017)
5.2 North America 3D Bioprinting Market Status by Manufacturers
5.3 North America 3D Bioprinting Market Status by Type (2013-2017)
5.3.1 North America 3D Bioprinting Sales by Type (2013-2017)
5.3.2 North America 3D Bioprinting Revenue by Type (2013-2017)
5.4 North America 3D Bioprinting Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe 3D Bioprinting Market Status by Countries
6.1.1 Europe 3D Bioprinting Sales by Countries (2013-2017)
6.1.2 Europe 3D Bioprinting Revenue by Countries (2013-2017)
6.1.3 Germany 3D Bioprinting Market Status (2013-2017)
6.1.4 UK 3D Bioprinting Market Status (2013-2017)
6.1.5 France 3D Bioprinting Market Status (2013-2017)
6.1.6 Italy 3D Bioprinting Market Status (2013-2017)
6.1.7 Russia 3D Bioprinting Market Status (2013-2017)
6.1.8 Spain 3D Bioprinting Market Status (2013-2017)
6.1.9 Benelux 3D Bioprinting Market Status (2013-2017)
6.2 Europe 3D Bioprinting Market Status by Manufacturers
6.3 Europe 3D Bioprinting Market Status by Type (2013-2017)
6.3.1 Europe 3D Bioprinting Sales by Type (2013-2017)
6.3.2 Europe 3D Bioprinting Revenue by Type (2013-2017)
6.4 Europe 3D Bioprinting Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific 3D Bioprinting Market Status by Countries
7.1.1 Asia Pacific 3D Bioprinting Sales by Countries (2013-2017)
7.1.2 Asia Pacific 3D Bioprinting Revenue by Countries (2013-2017)
7.1.3 China 3D Bioprinting Market Status (2013-2017)
7.1.4 Japan 3D Bioprinting Market Status (2013-2017)
7.1.5 India 3D Bioprinting Market Status (2013-2017)
7.1.6 Southeast Asia 3D Bioprinting Market Status (2013-2017)
7.1.7 Australia 3D Bioprinting Market Status (2013-2017)
7.2 Asia Pacific 3D Bioprinting Market Status by Manufacturers
7.3 Asia Pacific 3D Bioprinting Market Status by Type (2013-2017)
7.3.1 Asia Pacific 3D Bioprinting Sales by Type (2013-2017)
7.3.2 Asia Pacific 3D Bioprinting Revenue by Type (2013-2017)
7.4 Asia Pacific 3D Bioprinting Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America 3D Bioprinting Market Status by Countries
8.1.1 Latin America 3D Bioprinting Sales by Countries (2013-2017)
8.1.2 Latin America 3D Bioprinting Revenue by Countries (2013-2017)
8.1.3 Brazil 3D Bioprinting Market Status (2013-2017)
8.1.4 Argentina 3D Bioprinting Market Status (2013-2017)
8.1.5 Colombia 3D Bioprinting Market Status (2013-2017)
8.2 Latin America 3D Bioprinting Market Status by Manufacturers
8.3 Latin America 3D Bioprinting Market Status by Type (2013-2017)
8.3.1 Latin America 3D Bioprinting Sales by Type (2013-2017)
8.3.2 Latin America 3D Bioprinting Revenue by Type (2013-2017)
8.4 Latin America 3D Bioprinting Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa 3D Bioprinting Market Status by Countries
9.1.1 Middle East and Africa 3D Bioprinting Sales by Countries (2013-2017)
9.1.2 Middle East and Africa 3D Bioprinting Revenue by Countries (2013-2017)
9.1.3 Middle East 3D Bioprinting Market Status (2013-2017)
9.1.4 Africa 3D Bioprinting Market Status (2013-2017)
9.2 Middle East and Africa 3D Bioprinting Market Status by Manufacturers
9.3 Middle East and Africa 3D Bioprinting Market Status by Type (2013-2017)
9.3.1 Middle East and Africa 3D Bioprinting Sales by Type (2013-2017)
9.3.2 Middle East and Africa 3D Bioprinting Revenue by Type (2013-2017)
9.4 Middle East and Africa 3D Bioprinting Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF 3D BIOPRINTING
10.1 Global Economy Situation and Trend Overview
10.2 3D Bioprinting Downstream Industry Situation and Trend Overview
CHAPTER 11 3D BIOPRINTING MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of 3D Bioprinting by Major Manufacturers
11.2 Production Value of 3D Bioprinting by Major Manufacturers
11.3 Basic Information of 3D Bioprinting by Major Manufacturers
11.3.1 Headquarters Location and Established Time of 3D Bioprinting Major Manufacturer
11.3.2 Employees and Revenue Level of 3D Bioprinting Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 3D BIOPRINTING MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Organovo Holdings Inc.
12.1.1 Company profile
12.1.2 Representative 3D Bioprinting Product
12.1.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of Organovo Holdings Inc.
12.2 EnvisionTEC GmbH
12.2.1 Company profile
12.2.2 Representative 3D Bioprinting Product
12.2.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of EnvisionTEC GmbH
12.3 Nano3D Biosciences, Inc.
12.3.1 Company profile
12.3.2 Representative 3D Bioprinting Product
12.3.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of Nano3D Biosciences, Inc.
12.4 Cyfuse Biomedical K.K.
12.4.1 Company profile
12.4.2 Representative 3D Bioprinting Product
12.4.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of Cyfuse Biomedical K.K.
12.5 BioBots
12.5.1 Company profile
12.5.2 Representative 3D Bioprinting Product
12.5.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of BioBots
12.6 Aspect Biosystems Ltd.
12.6.1 Company profile
12.6.2 Representative 3D Bioprinting Product
12.6.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of Aspect Biosystems Ltd.
12.7 3Dynamic Systems Ltd.
12.7.1 Company profile
12.7.2 Representative 3D Bioprinting Product
12.7.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of 3Dynamic Systems Ltd.
12.8 regenHU Ltd
12.8.1 Company profile
12.8.2 Representative 3D Bioprinting Product
12.8.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of regenHU Ltd
12.9 Cellink
12.9.1 Company profile
12.9.2 Representative 3D Bioprinting Product
12.9.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of Cellink
12.10 Regenovo Biotechnology Co., Ltd.
12.10.1 Company profile
12.10.2 Representative 3D Bioprinting Product
12.10.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of Regenovo Biotechnology Co., Ltd.
12.11 Poietis
12.11.1 Company profile
12.11.2 Representative 3D Bioprinting Product
12.11.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of Poietis
12.12 GeSiM
12.12.1 Company profile
12.12.2 Representative 3D Bioprinting Product
12.12.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of GeSiM
12.13 Exone
12.13.1 Company profile
12.13.2 Representative 3D Bioprinting Product
12.13.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of Exone
12.14 Stratasys
12.14.1 Company profile
12.14.2 Representative 3D Bioprinting Product
12.14.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of Stratasys
12.15 Bespoke Innovations
12.15.1 Company profile
12.15.2 Representative 3D Bioprinting Product
12.15.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of Bespoke Innovations
12.16 Advanced BioMatrix
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF 3D BIOPRINTING
13.1 Industry Chain of 3D Bioprinting
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF 3D BIOPRINTING
14.1 Cost Structure Analysis of 3D Bioprinting
14.2 Raw Materials Cost Analysis of 3D Bioprinting
14.3 Labor Cost Analysis of 3D Bioprinting
14.4 Manufacturing Expenses Analysis of 3D Bioprinting
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
